Condition

CNS Lymphoma clinical trials and research

• 7Clinical trials
• 4Countries

Newest CNS Lymphoma clinical trials

All recruiting trials (7)

• Treatment of relapsed CNS large B-cell lymphoma with Relma-cel and Tislelizumab

  This study is testing a new treatment combining a cellular therapy and an immunotherapy for people with relapsed central nervous system large B-cell lymphoma to see if it helps them feel better and live longer.

  Recruiting Phase 2 Ruijin Hospital · Beijing and 5 other locations · NCT06876688

• Zanubrutinib combined with chemotherapy for patients with secondary CNS lymphoma

  This study is testing if a new combination of medications, including Zanubrutinib and chemotherapy, can help people with secondary Central Nervous System lymphoma feel better and improve their health.

  Recruiting Phase 1 University of Miami · Miami, Florida · NCT06730542

• T-Cell Therapy for Adults with Relapsed B-Cell Non-Hodgkin's Lymphoma

  This study is testing a new T-cell therapy to see if it can help adults with relapsed B-cell non-Hodgkin's lymphoma feel better.

  Recruiting at 5 sites Phase 1/2 Estrella Immunopharma, Inc. · Sacramento, California and 4 other locations · NCT06343311

• Treatment of CNS lymphoma using targeted endoradiotherapy

  This study is testing a new treatment for patients with recurrent or hard-to-treat central nervous system lymphoma to see if it is safe and effective.

  Recruiting Phase 1/2 Pentixapharm AG · Munich, Bavaria and 1 other locations · NCT06132737

• CLIMB: using scans and tissue biomarkers to learn more about primary CNS lymphoma

  This project will try to use brain scans and tumour tissue from adults with newly diagnosed primary CNS lymphoma to find markers that predict treatment response and time without disease progression.

  Recruiting Royal Marsden NHS Foundation Trust · Sutton · NCT05828628

• Combination treatment of Tafasitamab and Lenalidomide for relapsed CNS lymphoma

  This study is testing a combination of two drugs, Tafasitamab and Lenalidomide, to see if they can help people with relapsed central nervous system lymphoma feel better and improve their treatment outcomes.

  Recruiting Phase 1/2 University of California, San Francisco · San Francisco, California · NCT05351593

• Testing a new CAR T cell therapy for adolescents and adults with relapsed B-cell Non-Hodgkin Lymphoma

  This study is testing a new CAR T cell therapy to see if it can help adolescents and adults with relapsed B-cell Non-Hodgkin Lymphoma feel better and improve their chances of recovery.

  Recruiting Phase 1 University of Colorado, Denver · Aurora, Colorado · NCT05098613

Related topics

Quick answers

How many CNS Lymphoma clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (4 trials), China (1 trial), United Kingdom (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →